Table: Pharmarise Holdings - 9-MTH group results

Pharmarise Holdings

14/04/2017 07:00

Apr 14 (Reuters)-  
             Pharmarise Holdings Corp  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                   9 months ended      9 months ended       Year to  
                  Feb 28, 2017        Feb 29, 2016     May 31, 2017  
                     LATEST             YEAR-AGO          LATEST     
                     RESULTS             RESULTS         FORECAST    
  Sales               37.95               35.07            52.50     
                   (+8.2 pct)          (+20.0 pct)      (+8.2 pct)   
  Operating          271 mln             726 mln          500 mln    
                   (-62.6 pct)         (-5.4 pct)       (-38.5 pct)  
  Recurring          182 mln             602 mln          355 mln    
                   (-69.7 pct)         (-0.8 pct)       (-46.2 pct)  
  Net             loss 230 mln           662 mln          50 mln     
                                      (+367.2 pct)      (-86.9 pct)  
  EPS            loss 25.56 yen         73.51 yen        5.54 yen    
  EPS Diluted                           72.03 yen                    
  Ann Div                               14.00 yen        14.00 yen   
  -Q2 div              NIL                 NIL                       
  -Q4 div                               14.00 yen        14.00 yen   
   
  NOTE - Pharmarise Holdings Corp.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2796.T 
  ((Tokyo Headline News Desk +813 6441 1812))